The cost-benefit associated with the maturity of the Antimicrobial Stewardship Program versus prematurity in Heart Hospital of Hamad Medical Corporation in Qatar
<h3>Background</h3><p dir="ltr">Evidence suggests that approximately 70% of patients are on antimicrobials, alarmingly half of these prescribed antimicrobials are deemed inappropriate. We evaluated the cost-benefit of the antimicrobial stewardship program (ASP) in the Hea...
محفوظ في:
| المؤلف الرئيسي: | Dina Abushanab (10696501) (author) |
|---|---|
| مؤلفون آخرون: | Halima Saadia (18474702) (author), Mariam Mustafa (11790812) (author), Rasha Kaddoura (12506936) (author), Binny Thomas (5801969) (author), Palli Valappila Abdul Rouf (18472377) (author), Wessam Elkassem (18472434) (author), Moza Al Hail (2511859) (author), Daoud Al-Badriyeh (832403) (author) |
| منشور في: |
2023
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Cost-Benefit Analysis of Antimicrobial Stewardship Program Maturity in Adult Surgical Ward Settings: A Retrospective Study in Qatar
حسب: Nurhan Elshafey (18472387)
منشور في: (2024) -
Cost-Benefit Analysis of Antimicrobial Stewardship Program in the Adult General Medicine Setting in Qatar
حسب: Dina Abushanab (10696501)
منشور في: (2024) -
Cost-benefit analysis of antimicrobial stewardship program in a cancer setting in Qatar
حسب: Dina Abushanab (10696501)
منشور في: (2024) -
Cost-Benefit Analysis of Antimicrobial Stewardship Program in Women’s Health at Hamad Medical Corporation in Qatar
حسب: Dina Abushanab (10696501)
منشور في: (2023) -
Cost‑effectiveness of add‑on dapagliflozin for heart failure with reduced ejection fraction in patients without diabetes in Qatar.
حسب: Dina Abushanab (10696501)
منشور في: (2024)